Bristol-myers Squibb Stock Forecast

Sell candidate since Jun 18, 2026 Gain 1.30%

The Bristol-Myers Squibb stock price gained 1.30% on the last trading day (Monday, 22nd Jun 2026), rising from $54.00 to $54.70. During the last trading day the stock fluctuated 1.36% from a day low at $54.00 to a day high of $54.73. The price has fallen in 6 of the last 10 days and is down by -4.49% for this period. Volume fell on the last day by -16 million shares and in total, 11 million shares were bought and sold for approximately $605.26 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $53.94 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.32% during the next 3 months and, with a 90% probability hold a price between $50.53 and $54.56 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BMY Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 1.30%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bristol-Myers Squibb stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $55.74 and $56.64. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Friday, November 21, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Bristol-Myers Squibb stock

Bristol-Myers Squibb finds support from accumulated volume at $54.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.735 between high and low, or 1.36%. For the last week, the stock has had daily average volatility of 2.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMY) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Bristol-Myers Squibb Company to open at $54.48, and during the day (based on 14 day Average True Range), to move between $54.03 and $55.37, which gives a possible trading interval of +/-$1.35 (+/-2.49%) up or down from last closing price. If Bristol-Myers Squibb Company takes out the full calculated possible swing range there will be an estimated 2.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $54.46 (0.44%) than the resistance at $54.95 (0.46%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Dividend Warning For BMY

Dividend coming up for BMY: Ex-dividend date (Thursday 2nd July, 2026) is 8 days away. The dividend is $0.630.

Is Bristol-Myers Squibb Company stock A Buy?

Bristol-Myers Squibb holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.932 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $54.48 ( 0.411%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk